Abnormal Uterine Bleeding Clinical Trials

7 recruiting

Abnormal Uterine Bleeding Trials at a Glance

9 actively recruiting trials for abnormal uterine bleeding are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Beijing, Bordeaux, and Cincinnati. Lead sponsors running abnormal uterine bleeding studies include Assiut University, Channel Medsystems, and Aesculap AG.

Browse abnormal uterine bleeding trials by phase

Treatments under study

About Abnormal Uterine Bleeding Clinical Trials

Looking for clinical trials for Abnormal Uterine Bleeding? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Abnormal Uterine Bleeding trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Abnormal Uterine Bleeding clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

Abnormal Uterine Bleeding Due to Adenomyosis (Disorder)
University Hospital, Bordeaux230 enrolled4 locationsNCT07195305
Recruiting

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Endometrial CancerEndometrial Intraepithelial NeoplasiaAtypical Endometrial Hyperplasia+2 more
Exact Sciences Corporation4,200 enrolled1 locationNCT07544680
Recruiting
Not Applicable

The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial

Abnormal Uterine BleedingPain in Endometrial Biopsy
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization120 enrolled1 locationNCT07496905
Recruiting
Phase 1

Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding

Abnormal Uterine Bleeding
ScinnoHub Pharmaceutical Co., Ltd.39 enrolled1 locationNCT07169214
Recruiting

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

Abnormal Uterine BleedingHeavy Menstrual BleedingMenorrhagia
Channel Medsystems300 enrolled2 locationsNCT05922657
Recruiting
Phase 1

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

AnalgesiaAbnormal Uterine BleedingParacervical Block
Icahn School of Medicine at Mount Sinai60 enrolled1 locationNCT06653400
Recruiting
Not Applicable

Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder

Abnormal Uterine BleedingCesarean Section Complications
Assiut University30 enrolled1 locationNCT07183501
Recruiting

Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy

Ovarian CancerCervical CancerEndometrial Cancer+5 more
Aesculap AG132 enrolled2 locationsNCT06024109
Recruiting
Phase 3

Intrauterine Lidocaine versus Placebo in Conjunction with Paracervical Block for Pain Relief During Fractional Curettage: A Randomized Controlled Trial

Pain score in women with abnormal uterine bleeding who undergoing fractional and curettageAdverse effects in women with abnormal uterine bleeding who undergoing fractional and curettageAdditional drug requirement in women with abnormal uterine bleeding who undergoing fractional and curettage
Khon Kaen Hospital230 enrolled1 locationACTRN12611000449932